SCHEMBL23601797

SCHEMBL23601797

CN(c1cccc(-c2ccc(N3CCC3=O)cc2)c1)c1nc2nncn2c2cc(Cl)ccc12

nearest known ligand 0.34

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAT2A P31153 10/20 0.34
PRMT5 O14744 4/20 0.34
CYP1A2 P05177 1/20 0.34
MAPT P10636 1/20 0.34
FNTA P49354 2/20 0.34
FNTB P49356 1/20 0.34
TSHR P16473 1/20 0.33
F10 P00742 1/20 0.33
CYP3A4 P08684 1/20 0.32
PGGT1B P53609 1/20 0.32
PTGS2 P35354 1/20 0.32
HRH4 Q9H3N8 1/20 0.32
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
HPGD P15428 1/20 0.31
HTT P42858 1/20 0.31
KMT2A Q03164 1/20 0.31
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29909485 1.00 MAT2A (0.34) MAT2APRMT5CYP1A2MAPTFNTA
SCHEMBL23577711 0.95 TSHR (0.39) MAT2APRMT5CYP1A2MAPTFNTA
SCHEMBL29909770 0.95 TSHR (0.39) MAT2APRMT5CYP1A2MAPTFNTA
SCHEMBL23601269 0.94 F10 (0.40) MAT2APRMT5CYP1A2MAPTFNTA
SCHEMBL24721684 0.89 FNTA (0.35) MAT2APRMT5CYP1A2MAPTFNTA
SCHEMBL23600544 0.89 ENPP2 (0.36) MAT2APRMT5CYP1A2MAPTFNTA
SCHEMBL29909756 0.88 GRM5 (0.34) MAT2APRMT5CYP1A2FNTAFNTB
SCHEMBL23578111 0.88 GRM5 (0.34) MAT2APRMT5CYP1A2FNTAFNTB
SCHEMBL23601235 0.87 FNTA (0.40) MAT2APRMT5CYP1A2MAPTFNTA
SCHEMBL29909768 0.87 FNTA (0.40) MAT2APRMT5CYP1A2MAPTFNTA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220324866-A1 DIACYLGLYCEROL KINASE MODULATING COMPOUNDS GILEAD SCIENCES, INC. 2022-10-13 US disclosed
WO-2021130638-A1 DIACYLGLYCEROL KINASE MODULATING COMPOUNDS CARNA BIOSCIENCES, INC. (JP) 2021-07-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220324866-A1 DIACYLGLYCEROL KINASE MODULATING COMPOUNDS DGKG, DGKB, DGKK MAT2A 1551/4885PRMT5 2301/4885CYP1A2 4595/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.